# A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and Qatar

> **NCT03205618** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 182 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT03205618
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-26
- **Primary completion:** 2017-06-27
- **Final completion:** 2017-06-27
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03205618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03205618, "A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and Qatar". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03205618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*